Press release
Diabetic Macular Edema Market Growing at a Rapid Pace: Key Research and Players - Novartis AG, Regeneron Pharmaceuticals, Inc., Genentech, Inc.
Diabetic Macular Edema Market || 2024-2031
Get a Free Sample PDF - https://datamintelligence.com/download-sample/diabetic-macular-edema-market
What is the projected growth rate (CAGR) of the Global Diabetic Macular Edema market from 2024 to 2031, and what is the market value expected to change by 2031?
The Global Diabetic Macular Edema Market reached US$ 3.27 billion in 2023 and is expected to reach US$ 4.55 billion by 2031 growing with a CAGR of 4.2% during the forecast period 2024-2031.
What is Diabetic Macular Edema Market?
Diabetic Macular Edema (DME) is an eye condition that occurs in people with diabetes and is a leading cause of vision loss. It develops when high blood sugar levels damage the blood vessels in the retina, causing them to leak fluid into the macula, the part of the retina responsible for sharp, central vision. This fluid buildup causes the macula to swell, leading to blurred or distorted vision. If left untreated, DME can result in permanent vision impairment or blindness. Treatment options include laser therapy, anti-VEGF injections, and corticosteroids to reduce swelling and prevent further damage.
Who are the major players in the Diabetic Macular Edema market?
The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world. The prominent players in Diabetic Macular Edema market research report are:
Novartis AG, Regeneron Pharmaceuticals, Inc., Genentech, Inc., Eluminex Biosciences, Biocon, Formycon AG, Lupin, Bayer AG, Santen Pharmaceutical Co., Ltd., and F. Hoffmann-La Roche Ltd.
Key Development
In March 2024, Formycon AG and MS Pharma announced that their biosimilar FYB201, marketed as Ravegza, received marketing authorization from the Saudi Food & Drug Authority. Ravegza, a biosimilar of Lucentis (Ranibizumab), is approved in Saudi Arabia for the treatment of age-related neovascular (wet) macular degeneration (nAMD) and other serious eye conditions, including diabetic retinopathies.
Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=diabetic-macular-edema-market
Regions Covered:
The global Diabetic Macular Edema Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.
☞ North America - US, Canada, Mexico
☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe
☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific
☞ South America- Brazil, Argentina, Rest of South America
☞ Middle East and Africa
Market Segments
By Type: Serotonin-Receptor Antagonists, Anticholinergics, Glucocorticoids, Dopamine Receptor Antagonists, Neurokinin Receptor Antagonists, Others
By Treatment: Anti-Vascular Endothelial Growth Factor (VEGF) Medications, Corticosteroid Therapies, Laser Photocoagulation, Others
By Form: Intravitreal Injections, Intravitreal Implants
By End-User: Hospitals, Specialty Clinics, Home Care, Others
The Diabetic Macular Edema industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.
Key Features
➥ Leverage epidemiology insights to tailor precision diagnostics and address region-specific needs.
➥ Meet critical unmet needs in complex conditions with advanced, precise Diabetic Macular Edema industry solutions for better diagnostics and outcomes.
➥ Stay ahead with real-time pipeline analysis, revealing the latest Diabetic Macular Edema innovations and market trends.
➥ Optimize your offerings with competitive pricing analysis, balancing cost-effectiveness and cutting-edge tech.
➥ Protect your innovation with expert patent analysis, ensuring strategic positioning in the Diabetic Macular Edema market.
➥ Gain an edge with comprehensive competitive intelligence, guiding informed decisions in Diabetic Macular Edema
➥ Maximize market presence with brand share analysis, strengthening your position in the Diabetic Macular Edema landscape.
➥ Accurately predict market demand for Diabetic Macular Edema with precise drug sales forecasting insights.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/diabetic-macular-edema-market
FAQs
What does the Diabetic Macular Edema market report provide?
The report provides a detailed analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Active, Innovators, Start-ups, and Cutting Edge) that are anticipated to influence its future growth trajectory.
What is the scope of the market report?
The market report covers regional analysis and provides detailed insights into the Diabetic Macular Edema market including market size, segmentation, and key players.
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Macular Edema Market Growing at a Rapid Pace: Key Research and Players - Novartis AG, Regeneron Pharmaceuticals, Inc., Genentech, Inc. here
News-ID: 3706439 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Smart Factory Market to Reach US$ 290.6 Billion by 2033 at 12.6% CAGR; North Ame …
The Global Smart Factory Market reached US$ 112.4 billion in 2024 and is expected to reach US$ 290.6 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033. Market growth is driven by increasing adoption of Industry 4.0 practices, rising demand for automation and operational efficiency, and growing integration of digital technologies across manufacturing industries.
Smart factories leverage advanced technologies such as the Industrial Internet of Things…
Smart Factory Market to Reach US$ 290.6 Billion by 2033 at 12.6% CAGR; North Ame …
The Global Smart Factory Market reached US$ 112.4 billion in 2024 and is expected to reach US$ 290.6 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033. Market growth is driven by increasing adoption of Industry 4.0 practices, rising demand for automation and operational efficiency, and growing integration of digital technologies across manufacturing industries.
Smart factories leverage advanced technologies such as the Industrial Internet of Things…
Radiofrequency Ablation Devices Market to Reach US$ 13.54 Billion by 2033 at 10. …
The Global Radiofrequency Ablation Devices Market reached US$ 5.63 billion in 2024 and is expected to reach US$ 13.54 billion by 2033, growing at a CAGR of 10.7% during the forecast period 2025-2033. Market growth is driven by the rising prevalence of chronic pain conditions and cancer, increasing preference for minimally invasive procedures, and advancements in ablation technologies.
Radiofrequency ablation devices are used to treat tumors, cardiac arrhythmias, and chronic pain…
Mobile Threat Defense (MTD) Market to Reach US$ 10.5 Billion by 2030, Growing at …
According to DataM Intelligence, the global Mobile Threat Defense (MTD) market reached US$ 2.2 billion in 2022 and is expected to reach US$ 10.5 billion by 2030, growing at a CAGR of 22.0% during the forecast period 2024-2031. This growth is propelled by the rapid surge in mobile malware, phishing, and ransomware attacks targeting enterprises, increasing adoption of BYOD and remote work policies, strong demand for cloud-based MTD solutions, rising…
More Releases for Diabetic
Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025?
The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
